Test
Back to all Representative Matters
Feb 24, 2021

5045299 Completes Disposition of Common Shares and Options of Greenland Resources Inc.

Jeffrey K. Merk

5045299 Ontario Inc. (“5045299”), a corporation formed on the amalgamation of 2449539 Ontario Inc. and Gupta Group Mining and Resources Inc., has disposed of 17,333,333 common shares (the “Shares”) in the capital of Greenland Resources Inc. (“Greenland”). It also disposed of an option to acquire 600,000 common shares in the capital of Greenland (the “Options”) through a private sale transaction pursuant to a securities purchase agreement, totalling an aggregate of $2,149,333.29 for the Shares and $766.71 for the Options (the “Transaction”).

Aird & Berlis lawyers Jeffrey Merk and David Mba represented 5045299 in the Transaction.

Related Representative Matters

Representative Matters
Brantford Power and Energy+ Merge to Form GrandBridge Energy Ron W. Clark, Lisa E. Moreau, Barbara Worndl, Dennis M. O'Leary, Danielle M. Shields, Emily Chittick, Christian Nianiaris, Sam Babe and Michael F. Horvat May 02, 2022 On May 2, 2022, Brantford Energy Corporation and Cambridge and North Dumfries Energy+ Inc. merged... On May 2, 2022, Brantford Energy Corporation and Cambridge and North Dumfries Energy+ Inc. merged to form GrandBridge Corporation, the shareholder of GrandBridge Energy Inc., GrandBridge Group Inc., and GrandBridge Solutions Inc.
Representative Matters
Harborside Inc. Completes Acquisition of Urbn Leaf Sherri M. Altshuler, Adria Leung Lim, Amy Marcen-Gaudaur and Meredith McCann Mar 08, 2022 On March 1, 2022, Harborside Inc. (CSE: HBOR) (OTCQX: HBORF), a California-focused, vertically-in... On March 1, 2022, Harborside Inc. (CSE: HBOR) (OTCQX: HBORF), a California-focused, vertically-integrated cannabis enterprise, completed the acquisition of UL Holdings Inc., a leading California cannabis retailer with a dominant position in southern California.
Representative Matters
Signet Healthcare Partners Completes Growth Equity Investment in Juno Pharmaceuticals Corp. Richard Epstein, Lorway Gosse, Aarondeep (Aaron) S. Bains and Francesco Gucciardo Feb 25, 2022 Juno Pharmaceuticals Corp., a Canadian specialty generics pharmaceuticals company, announced that... Juno Pharmaceuticals Corp., a Canadian specialty generics pharmaceuticals company, announced that it had received a strategic growth investment from Signet Healthcare Partners, a New York-based healthcare growth equity firm.